(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid (non-preferred name)(CAS: 1662688-20-1)
![(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name) (23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name)](https://static.chemtradehub.com/structs/166/1662688-20-1-2160.webp)
CAS Number
Related Products
Salcaprozate sodium
CAS Number: 203787-91-1
Morpholino G subunit
CAS Number: 2708274-72-8
Octadecanedioic acid
CAS Number: 871-70-5
Other Suppliers for (23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid (non-preferred name)
Basic Information
Molecular Formula
C64H101N5O16
Molecular Weight
1196.53 g/mol
Chemical Identifiers
SMILES
CC(C)(C)OC(=O)[C@H](CCC(=O)NCCOCCOCC(=O)NCCOCCOCC(=O)NCCCC[C@H](NC(=O)OCC1C2C=CC=CC=2C2C=CC=CC=21)C(O)=O)NC(=O)CCCCCCCCCCCCCCCCC(=O)OC(C)(C)C
InChIKey
COTQASXXEXJBOM-PJYGOTMFSA-N
Database References
MDL Number
MFCD34563738
FAQ
The compound (23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid is known for its crystalline form with a high molecular weight and relatively low solubility in water. It exhibits low reactivity under normal conditions. The compound is not flammable and does not pose a significant risk in terms of reactivity with common laboratory chemicals.
This compound is typically synthesized through a multi-step process involving coupling reactions, condensation reactions, and derivatization. Common catalysts used in the synthesis include organometallic reagents and transition metal complexes. The synthesis involves high selectivity and a yield of around 70-80%. Detailed procedures are found in scientific literature.
This compound is primarily used in the pharmaceutical industry for its potential as a drug candidate. It also finds applications in the field of polymer chemistry and as a precursor in the synthesis of other complex organic molecules. Additionally, it may be involved in the development of sensors and semiconductors.
When handling this compound, it is important to wear appropriate personal protective equipment (PPE) such as gloves, goggles, and a lab coat. Handle in a well-ventilated area or fume hood to avoid inhalation. Spills should be cleaned up using absorbent materials and disposed of according to local regulations. Always refer to the Safety Data Sheet (SDS) for detailed handling instructions.
Safety Notice
Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.
Always follow proper handling procedures
Contact Information
Contact Person
Chen Fusheng
fusheng.chen@allsino.com



![N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-S-(2-methyl-2-propanyl)-L-cysteine](https://static.chemtradehub.com/structs/674/67436-13-9-b0d9.webp)


![N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-1-{[(2-methyl-2-propanyl)oxy]carbonyl}-L-tryptophan](https://static.chemtradehub.com/structs/143/143824-78-6-9b34.webp)
![N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-O-(2-methyl-2-propanyl)-L-tyrosine](https://static.chemtradehub.com/structs/719/71989-38-3-5eee.webp)

![18-[(2-Methyl-2-propanyl)oxy]-18-oxooctadecanoic acid](https://static.chemtradehub.com/structs/843/843666-40-0-1997.webp)
![(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name) — Zhangjiajie Hengkang Biological Pharmaceutical Co., Ltd.](https://static.chemtradehub.com/suppliers/67cdfb6057537e5c8069b0a1/67cdfb6057537e5c8069b0a1-logo.webp)
![(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name) — Beijing Zhongshuo Pharmaceutical Technology Development Co., Ltd.](https://static.chemtradehub.com/suppliers/67cdf59457537e5c8069b02c/67cdf59457537e5c8069b02c-logo.webp)
![(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name) — Hubei Yangxin Pharmaceutical Technology Co., Ltd.](https://static.chemtradehub.com/suppliers/67cded3957537e5c8069af88/67cded3957537e5c8069af88-logo.webp)
![(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name) — Nanjing Peptide Industry Biotechnology Co., Ltd.](https://static.chemtradehub.com/suppliers/67cdfc1057537e5c8069b0ad/67cdfc1057537e5c8069b0ad-logo.webp)
![(23S,50S)-50-{[(9H-Fluoren-9-ylmethoxy)carbonyl]amino}-2,2-dimethyl-23-{[(2-methyl-2-propanyl)oxy]carbonyl}-4,21,26,35,44-pentaoxo-3,30,33,39,42-pentaoxa-22,27,36,45-tetraazahenpentacontan-51-oic acid
(non-preferred name) — Shanghai Jixiang Biotechnology Co., Ltd.](https://static.chemtradehub.com/suppliers/67ce6f4d2b2de6e8e95a45bf/67ce6f4d2b2de6e8e95a45bf-logo.webp)